Key result
Exercise training drives non-fibrotic physiological cardiac hypertrophy through distinct molecular and microRNA pathways.
Understanding the molecular pathways differentiating physiological from pathological cardiac hypertrophy may offer new therapeutic targets, such as microRNAs, for treating cardiac dysfunction.
Supports benign exercise-induced remodeling in athletes; leaves open microRNA targeting for pathological hypertrophy pending trials.
Among the molecular, biochemical and cellular processes that orchestrate the development of the different phenotypes of cardiac hypertrophy in response to physiological stimuli or pathological insults, the specific contribution of exercise training has recently become appreciated. Physiological cardiac hypertrophy involves complex cardiac remodeling that occurs as an adaptive response to static or dynamic chronic exercise, but the stimuli and molecular mechanisms underlying transduction of the hemodynamic overload into myocardial growth are poorly understood. This review summarizes the physiological stimuli that induce concentric and eccentric physiological hypertrophy, and discusses the molecular mechanisms, sarcomeric organization, and signaling pathway involved, also showing that the cardiac markers of pathological hypertrophy (atrial natriuretic factor, β-myosin heavy chain and α-skeletal actin) are not increased. There is no fibrosis and no cardiac dysfunction in eccentric or concentric hypertrophy induced by exercise training. Therefore, the renin-angiotensin system has been implicated as one of the regulatory mechanisms for the control of cardiac function and structure. Here, we show that the angiotensin II type 1 (AT1) receptor is locally activated in pathological and physiological cardiac hypertrophy, although with exercise training it can be stimulated independently of the involvement of angiotensin II. Recently, microRNAs (miRs) have been investigated as a possible therapeutic approach since they regulate the translation of the target mRNAs involved in cardiac hypertrophy; however, miRs in relation to physiological hypertrophy have not been extensively investigated. We summarize here profiling studies that have examined miRs in pathological and physiological cardiac hypertrophy. An understanding of physiological cardiac remodeling may provide a strategy to improve ventricular function in cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2011) conducted a review in Physiological cardiac hypertrophy. Exercise training was evaluated. Exercise training induces concentric and eccentric physiological cardiac hypertrophy via specific molecular mechanisms, including local AT1 receptor activation and microRNAs, without causing fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: